Proteasome inhibition using MG-132 selectively enhances radiation sensitivity in prostate cancer cells

被引：0
|
作者：
Warren, G
Grimes, K
Ponomareva, L
St Clair, D
St Clair, W
机构：
[1] Univ Kentucky, Dept Radiat Med, Lexington, KY 40536 USA
[2] Univ Kentucky, Dept Nutr Sci, Lexington, KY 40536 USA
[3] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2004年 / 60卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2045
引用
收藏
页码：S364 / S365
页数：2
相关论文
共 50 条
  • [1] Selectively enhanced radiation sensitivity in prostate cancer cells associated with proteasome inhibition
    Warren, G
    Grimes, K
    Xu, Y
    Kudrimoti, M
    St Clair, W
    ONCOLOGY REPORTS, 2006, 15 (05) : 1287 - 1291
  • [2] The proteasome inhibitor MG-132 sensitizes PC-3 prostate cancer cells to ionizing radiation by a DNA-PK-independent mechanism
    Pajonk, F
    van Ophoven, A
    Weissenberger, C
    McBride, WH
    BMC CANCER, 2005, 5 (1)
  • [3] The proteasome inhibitor MG-132 sensitizes PC-3 prostate cancer cells to ionizing radiation by a DNA-PK-independent mechanism
    Frank Pajonk
    Arndt van Ophoven
    Christian Weissenberger
    William H McBride
    BMC Cancer, 5
  • [4] Proteasome inhibitor MG-132 enhances whole-body protein turnover in rat
    Holecek, M
    Muthny, T
    Kovarik, M
    Sispera, L
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 345 (01) : 38 - 42
  • [5] Proteasome inhibition by MG-132 protects against deltamethrin-induced apoptosis in rat hippocampus
    Huang, Xiaowei
    Liang, Yanfang
    Qing, Yan
    Chen, Dan
    Shi, Nian
    LIFE SCIENCES, 2019, 220 : 76 - 83
  • [6] MCPIP1 contributes to the toxicity of proteasome inhibitor MG-132 in HeLa cells by the inhibition of NF-κB
    Skalniak, Lukasz
    Dziendziel, Monika
    Jura, Jolanta
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2014, 395 (1-2) : 253 - 263
  • [7] MCPIP1 contributes to the toxicity of proteasome inhibitor MG-132 in HeLa cells by the inhibition of NF-κB
    Lukasz Skalniak
    Monika Dziendziel
    Jolanta Jura
    Molecular and Cellular Biochemistry, 2014, 395 : 253 - 263
  • [8] MG132-mediated Suppression of the Ubiquitin-proteasome Pathway Enhances the Sensitivity of Endometrial Cancer Cells to Cisplatin
    Zhang, Zhanhu
    Ding, Yiqian
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2025, 25 (04) : 281 - 291
  • [9] Induction of apoptosis in primitive human AML cells using the proteasome inhibitor MG-132 and/or sodium salicylate.
    Guzman, HL
    Upchurch, D
    Grimes, B
    Howard, DS
    Phillips, GL
    Rizzieri, DA
    Luger, SM
    Jordan, CT
    BLOOD, 2000, 96 (11) : 80A - 80A
  • [10] Proteasome Inhibitor MG132 Enhances Sensitivity to Cisplatin on Ovarian Carcinoma Cells In Vitro and In Vivo
    Guo, Na
    Peng, Zhilan
    Zhang, Jiawen
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (05) : 839 - 844
12345